ZENEO® Hydrocortisone : Treatment for acute adrenal crisis
Acute adrenal crisis is recognizable by its typical symptoms of diarrhea, vomiting and nausea. Unfortunately, the delay between the apparition of these symptoms and the administration of emergency treatment is the principal cause of death.
Nearly 600,000 people in Europe and the United States are susceptible to acute adrenal crises (2).
These latter however, due to a lack of simple and rapid treatment solutions, sometimes do not benefit from correct management and thus become fatal for 6% of acute adrenal crisis victims (3).
In contrast to the current standard of care, which requires 15 pre-injection steps, ZENEO® Hydrocortisone ensures the rapid and safe administration of the treatment in this emergency setting.
(2) Datamonitor 2015
(3)ahner S, Spinnler C, Fassnacht M, Burger-Stritt S, Lang K, Milovanovic D, Beuschlein F, Willenberg HS, Quinkler M, AllolioB. High incidence of adrenalcrisis in educated patients with chronicadrenal insufficiency : a prospective study. J Clin Endocrinol Metab. 2015 fév;100(2):407-16. Doi : 10.1210/jc.2014-3191. Epub 2014 nov 24.
When experiencing an acute adrenal crisis, the patient can self-administer ZENEO® Hydrocortisone in the thigh.
Another person could also administer the product for the patient, in a ventrogluteal injection.